Yield10 Bioscience Stock Buy Hold or Sell Recommendation
| YTEN Stock | USD 0.23 0.03 11.54% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Yield10 Bioscience is 'Cautious Hold'. Macroaxis provides Yield10 Bioscience buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding YTEN positions. The advice algorithm takes into account all of Yield10 Bioscience's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Yield10 Bioscience's buy or sell advice are summarized below:
Real Value 0.88 | Target Price 2.83 | Hype Value 0.22 | Market Value 0.23 | Naive Value 0.22 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Yield10 Bioscience given historical horizon and risk tolerance towards Yield10 Bioscience. When Macroaxis issues a 'buy' or 'sell' recommendation for Yield10 Bioscience, the advice is generated through an automated system that utilizes algorithms and statistical models.
Yield10 |
Execute Yield10 Bioscience Buy or Sell Advice
The Yield10 recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Yield10 Bioscience. Macroaxis does not own or have any residual interests in Yield10 Bioscience or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Yield10 Bioscience's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Yield10 Bioscience Trading Alerts and Improvement Suggestions
| Yield10 Bioscience is way too risky over 90 days horizon | |
| Yield10 Bioscience has some characteristics of a very speculative penny stock | |
| Yield10 Bioscience appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 60 K. Net Loss for the year was (14.46 M) with loss before overhead, payroll, taxes, and interest of (7.3 M). | |
| Yield10 Bioscience currently holds about 10.16 M in cash with (10.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Yield10 Bioscience has a frail financial position based on the latest SEC disclosures | |
| Roughly 13.0% of the company outstanding shares are owned by insiders | |
| Latest headline from news.google.com: Yield10 Bioscience Stock Price Passes Above 200 Day Moving Average of 0.27 - Defense World |
Yield10 Bioscience Returns Distribution Density
The distribution of Yield10 Bioscience's historical returns is an attempt to chart the uncertainty of Yield10 Bioscience's future price movements. The chart of the probability distribution of Yield10 Bioscience daily returns describes the distribution of returns around its average expected value. We use Yield10 Bioscience price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Yield10 Bioscience returns is essential to provide solid investment advice for Yield10 Bioscience.
| Mean Return | 1.32 | Value At Risk | -10.81 | Potential Upside | 19.35 | Standard Deviation | 15.38 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Yield10 Bioscience historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Yield10 Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Yield10 Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Yield10 Bioscience backward and forwards among themselves. Yield10 Bioscience's institutional investor refers to the entity that pools money to purchase Yield10 Bioscience's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2023-12-31 | 14.3 K | Hrt Financial Llc | 2023-12-31 | 12.2 K | Tower Research Capital Llc | 2023-12-31 | 10.3 K | Wells Fargo & Co | 2023-12-31 | 36.0 | Ifp Advisors, Llc | 2023-12-31 | 30.0 | Vima Llc | 2023-12-31 | 12.0 | Salem Investment Counselors Inc | 2023-12-31 | 4.0 | Concord Wealth Partners | 2023-09-30 | 0.0 | Fmr Inc | 2023-09-30 | 0.0 | Cannell Peter B & Co Inc | 2023-12-31 | 248.1 K | Geode Capital Management, Llc | 2023-12-31 | 62.5 K |
Yield10 Bioscience Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 2.4M | (2.1M) | 1.9M | (3.0M) | (1.3M) | (1.2M) | |
| Free Cash Flow | (8.7M) | (8.7M) | (9.4M) | (11.6M) | (10.1M) | (10.6M) | |
| Depreciation | 203K | 182K | 220K | 263K | 290K | 275.5K | |
| Other Non Cash Items | 5.2M | 1.4M | 470K | 526K | 1.5M | 1.6M | |
| Capital Expenditures | 61K | 76K | 189K | 154K | 46K | 43.7K | |
| Net Income | (13.0M) | (10.2M) | (11.0M) | (13.6M) | (14.5M) | (15.2M) | |
| End Period Cash Flow | 5.7M | 3.7M | 5.6M | 2.6M | 1.1M | 1.0M | |
| Investments | (3.0M) | (645K) | (4.4M) | 8.5M | 3.5M | 3.5M | |
| Change Receivables | 69K | (40K) | 22K | (14K) | (16.1K) | (15.3K) | |
| Change To Netincome | (9.0M) | 2.2M | 2.2M | 2.6M | 2.3M | 2.5M |
Yield10 Bioscience Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Yield10 Bioscience or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Yield10 Bioscience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Yield10 stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 1.06 | |
β | Beta against NYSE Composite | 2.94 | |
σ | Overall volatility | 15.81 | |
Ir | Information ratio | 0.08 |
Yield10 Bioscience Volatility Alert
Yield10 Bioscience is showing large volatility of returns over the selected time horizon. Yield10 Bioscience is a potential penny stock. Although Yield10 Bioscience may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Yield10 Bioscience. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Yield10 instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Yield10 Bioscience Fundamentals Vs Peers
Comparing Yield10 Bioscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Yield10 Bioscience's direct or indirect competition across all of the common fundamentals between Yield10 Bioscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Yield10 Bioscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Yield10 Bioscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Yield10 Bioscience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Yield10 Bioscience to competition |
| Fundamentals | Yield10 Bioscience | Peer Average |
| Return On Equity | -15.08 | -0.31 |
| Return On Asset | -1.5 | -0.14 |
| Operating Margin | (240.28) % | (5.51) % |
| Current Valuation | 6.07 M | 16.62 B |
| Shares Outstanding | 15.4 M | 571.82 M |
| Shares Owned By Insiders | 12.60 % | 10.09 % |
| Shares Owned By Institutions | 3.96 % | 39.21 % |
| Number Of Shares Shorted | 940.87 K | 4.71 M |
| Price To Earning | (3.19) X | 28.72 X |
| Price To Book | 11.23 X | 9.51 X |
| Price To Sales | 79.63 X | 11.42 X |
| Revenue | 60 K | 9.43 B |
| Gross Profit | (7.3 M) | 27.38 B |
| EBITDA | (14.13 M) | 3.9 B |
| Net Income | (14.46 M) | 570.98 M |
| Cash And Equivalents | 10.16 M | 2.7 B |
| Cash Per Share | 2.07 X | 5.01 X |
| Total Debt | 3.18 M | 5.32 B |
| Debt To Equity | 0.28 % | 48.70 % |
| Current Ratio | 6.58 X | 2.16 X |
| Book Value Per Share | (0.21) X | 1.93 K |
| Cash Flow From Operations | (10.07 M) | 971.22 M |
| Short Ratio | 0.16 X | 4.00 X |
| Earnings Per Share | (1.82) X | 3.12 X |
| Target Price | 0.5 | |
| Number Of Employees | 29 | 18.84 K |
| Beta | 1.61 | -0.15 |
| Market Capitalization | 3.74 M | 19.03 B |
| Total Asset | 3.91 M | 29.47 B |
| Retained Earnings | (414.15 M) | 9.33 B |
| Working Capital | (3.46 M) | 1.48 B |
| Current Asset | 15.34 M | 9.34 B |
| Current Liabilities | 3.91 M | 7.9 B |
Note: Disposition of 988 shares by Kristi Snell of Yield10 Bioscience at 2.68 subject to Rule 16b-3 [view details]
Yield10 Bioscience Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Yield10 . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Yield10 Bioscience Buy or Sell Advice
When is the right time to buy or sell Yield10 Bioscience? Buying financial instruments such as Yield10 Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Total Liabilities | 4.4M | 3.7M | 6.4M | 6.1M | Other Stockholder Equity | 402.3M | 404.3M | 411.8M | 282.7M |
Use Investing Ideas to Build Portfolios
In addition to having Yield10 Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Market Neutral Funds Thematic Idea Now
Market Neutral Funds
Funds or Etfs that invest in both long and short positions of different entities to enhance returns from broad market movements over time. The Market Neutral Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Market Neutral Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Yield10 Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.Note that the Yield10 Bioscience information on this page should be used as a complementary analysis to other Yield10 Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Yield10 Stock analysis
When running Yield10 Bioscience's price analysis, check to measure Yield10 Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Yield10 Bioscience is operating at the current time. Most of Yield10 Bioscience's value examination focuses on studying past and present price action to predict the probability of Yield10 Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Yield10 Bioscience's price. Additionally, you may evaluate how the addition of Yield10 Bioscience to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stocks Directory Find actively traded stocks across global markets |
Is Yield10 Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Yield10 Bioscience. If investors know Yield10 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Yield10 Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.82) | Revenue Per Share 0.008 | Quarterly Revenue Growth (1.00) | Return On Assets (1.50) | Return On Equity (15.08) |
The market value of Yield10 Bioscience is measured differently than its book value, which is the value of Yield10 that is recorded on the company's balance sheet. Investors also form their own opinion of Yield10 Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Yield10 Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Yield10 Bioscience's market value can be influenced by many factors that don't directly affect Yield10 Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Yield10 Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Yield10 Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Yield10 Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.